Katsumi Imaida Selected Research

Katsumi Imaida Research Topics

Disease

37	Neoplasms (Cancer) 01/2023 - 02/2002
35	Carcinogenesis 06/2021 - 02/2002
20	Adenoma (Adenomas) 01/2020 - 02/2002
13	Adenocarcinoma 01/2020 - 02/2002
9	Hyperplasia 10/2018 - 10/2002
9	Carcinoma (Carcinomatosis) 12/2014 - 02/2002
8	Body Weight (Weight, Body) 01/2020 - 11/2003
7	Inflammation (Inflammations) 06/2021 - 09/2009
6	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2007
4	Neoplasm Metastasis (Metastasis) 08/2014 - 10/2002
4	Adenocarcinoma of Lung 05/2014 - 07/2009
4	Colorectal Neoplasms (Colorectal Cancer) 10/2007 - 10/2002
4	Lymphatic Metastasis 07/2004 - 10/2002
3	Fibrosis (Cirrhosis) 01/2020 - 01/2010
3	Pneumonia (Pneumonitis) 10/2018 - 03/2014
2	Hypertrophy 01/2020 - 01/2018
2	Aberrant Crypt Foci 03/2010 - 02/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2008 - 07/2007
2	Prostatic Neoplasms (Prostate Cancer) 12/2002 - 10/2002
1	Granuloma 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Silicosis 01/2020
1	Diabetes Mellitus 01/2020
1	Genomic Instability 07/2018
1	Pulmonary Edema 04/2017
1	Anemia 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Obesity 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Necrosis 01/2017
1	Stomach Neoplasms (Stomach Cancer) 08/2014

Drug/Important Bio-Agent (IBA)

13	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 12/2014 - 11/2003
10	CarcinogensIBA 06/2021 - 10/2002
8	QuartzIBA 01/2020 - 09/2009
8	diisopropanolnitrosamineIBA 10/2018 - 02/2008
6	NitrosaminesIBA 07/2018 - 07/2007
6	Methoxsalen (Oxsoralen)FDA Link 07/2009 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2007
5	QuinoxalinesIBA 03/2010 - 02/2008
4	benzocycloheptapyridineIBA 01/2010 - 02/2002
4	Messenger RNA (mRNA)IBA 11/2008 - 03/2006
3	ErbB Receptors (EGF Receptor)IBA 12/2014 - 02/2008
3	Urethane (Ethyl Carbamate)IBA 11/2012 - 02/2008
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2012 - 11/2005
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 03/2010 - 02/2002
3	EnzymesIBA 03/2010 - 03/2006
3	Dimenhydrinate (DMH)FDA LinkGeneric 03/2010 - 02/2002
3	AminesIBA 01/2010 - 02/2005
3	Cyclin B1IBA 07/2004 - 05/2003
3	Cyclin AIBA 07/2004 - 10/2002
3	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 12/2002 - 02/2002
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2018
2	Ambroxol (Mucosolvan)IBA 10/2018 - 04/2017
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 10/2018 - 10/2014
2	Codon (Codons)IBA 01/2016 - 02/2008
2	ParaffinIBA 10/2014 - 03/2014
2	Drinking WaterIBA 10/2014 - 09/2009
2	Formaldehyde (Formol)FDA Link 10/2014 - 03/2014
2	SmokeIBA 12/2012 - 10/2007
2	Nicotine FDA Link 12/2012 - 01/2012
2	Phosphotransferases (Kinase)IBA 02/2009 - 11/2008
2	Protein SIBA 11/2008 - 11/2005
2	Cyclin-Dependent Kinase Inhibitor p27IBA 11/2008 - 10/2002
2	steroid hormone 7-alpha-hydroxylaseIBA 10/2008 - 11/2005
2	AndrogensIBA 04/2006 - 06/2005
2	Tumor Viral Antigens (Large T Antigen)IBA 06/2005 - 05/2005
2	probasinIBA 06/2005 - 05/2005
2	Cyclin EIBA 07/2004 - 12/2003
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	CreatinineIBA 01/2020
1	NitrogenIBA 01/2020
1	BilirubinIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 07/2018
1	Expectorants (Mucolytics)IBA 04/2017
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017
1	alpha-ChlorohydrinIBA 01/2017
1	Culture MediaIBA 01/2017
1	MitogensIBA 01/2016
1	Mitogen-Activated Protein Kinase 3IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 11/2015
1	Pemetrexed (MTA)FDA Link 11/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2014
1	Hormones (Hormone)IBA 12/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2014
1	Estrogen ReceptorsIBA 12/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2014
1	Fenofibrate (CiL)FDA LinkGeneric 05/2014
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2014

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2015 - 08/2014
2	Chemoprevention 09/2008 - 02/2002
1	Radiofrequency Ablation 08/2014
1	Gastrectomy 08/2014